Genes and Alzheimer's disease;Alzheimers sygdom og generne

Ugeskrift for Laeger

Volumn 159, Issue 38, 1997, Pages 5648-5652

  Jørgensen, Arne Lund ^a   Johannsen, Peter ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ALZHEIMER DISEASE; DOMINANT GENE; GENETIC POLYMORPHISM; GENETICS; HUMAN; REVIEW;

ALZHEIMER DISEASE; APOLIPOPROTEINS E; GENES, DOMINANT; HUMANS; POLYMORPHISM, GENETIC;

EID: 0031571807     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Jellinger K, Danielczyk W, Fischer P, Gabriel E. Clinicopathological analysis of dementia disorders in the elderly. J Neurol Sci 1990; 95: 239-58.
2. Saunders AM, Hulette C, Welsh-Bohmer KA, Schmechel DE, Crain B, Burke JR et al. Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease. Lancet 1996; 348: 90-3.
3. Räihä I, Kaprio J, Koskenvuo M, Rajala T, Sourander L. Alzheimer's disease in Finnish twins. Lancet 1996; 347: 573-8.
4. Schoenberg BS, Kokmen E, Okazaki H. Alzheimer's disease and other dementing illnesses in a defined United States population: incidence rates and clinical features. Ann Neurol 1987; 22: 724-9.
5. Rocca WA, Hofman A, Brayne C, Breteler MMB, Clarke M, Copeland JRM et al. Frequency and distribution of Alzheimer's disease in Europe: a collaborative study of 1980-1990 prevalence findings. Ann Neurol 1991; 30: 381-90.
6. Heston LL, Mastri AR, Anderson VE, White J. Dementia of the Alzheimer type. Clinical genetics, natural history, and associated conditions. Arch Gen Psychiatry 1981; 38: 1085 90.
7. Van Duijn CM, Hofman A. Risk factors for Alzheimer's disease: A collaborative reanalysis of case-control studies. Int J Epidemiol 1991; 20 (suppl 2): 2-73.
8. Mayeux R, Ottman R, Maestre G, Ngai C, Tang M-X, Ginsberg H et al. Synergistic effects of traumatic head injury and apolipoprotein-ε4 in patients with Alzheimer's disease. Neurology 1995; 45: 555-7.
9. Sorbi S, Nacmias B, Piacentini S, Repice A, Latorraca S, Forleo P et al. ApoE as a prognostic factor for post-traumatic coma. Nature Med 1995; 1: 852.
10. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995; 375: 754-60.
11. Levy-Lahad E, Wijsman EM, Nemens E, Anderson L, Goddard KAB, Weber JL et al. A familial Alzheimer's disease locus on chromosome 1. Science 1995; 269: 970-3.
12. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995; 269: 973-7.
13. Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 1995; 376: 775-8.
14. Goate A, Chartier-Harlin M-C, Mullan M, Brown J, Crawford F, Fidani L et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991; 349: 704-6.
15. Alzheimer's Disease Collaborative Group. The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Nature Genet 1995; 11: 219-22.
16. Jørgensen P, Bus C, Pallisgaard N, Bryder M, Jørgensen AL. Familial Alzheimer's disease co-segregates with a Met146Ile substitution in presenilin-1. Clin Genet 1996; 50: 281-6.
17. Campion D, Flaman J-M, Brice A, Mannequin D, Dubois B, Martin C et al. Mutations of the presenilin I gene in families with early-onset Alzheimer's disease. Hum Mol Genet 1995; 4: 2373-7.
18. Cruts M, Backhovens H, Wang S-Y, van Gassen G, Theuns J, De Jonghe CD et al. Molecular genetic analysis of familial early-onset Alzheimer's disease linked to chromosome 14q24.3. Hum Mol Genet 1995; 4: 2363-71.
19. Van Broeckhoven C. Presenilins and Alzheimer disease. Nature Genet 1995; 11: 230-2.
20. Roses AD. Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annu Rev Med 1996; 47: 387-400.
21. Sherrington R, Froelich S, Sorbi S, Campion D, Chi H, Rogaeva EA et al. Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant. Hum Mol Genet. 1996; 5: 985-8.
22. Ashall F, Goate AM. Role of the β-amyloid precursor protein in Alzheimer's disease. Trends Biochem Sci 1994; 19: 42-6.
23. St George-Hyslop P, McLachlan DC, Tsuda T, Rogaev E, Karlinsky H, Lippa CF et al. Alzheimer's disease and possible gene interaction. Science 1994; 263: 537.
24. Higuchi S, Matsushita S, Hasegawa Y, Muramatsu T, Ita-bashi S, Arai H. S182 and STM2 gene missense mutations in sporadic Alzheimer disease. Am J Med Genet 1996; 67: 429.
25. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS et al. Apolipoprotein E: high-avidity binding to β-amylotd and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci 1993; 90: 1977-81.
26. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-3.
27. Saunders AM, Strittmatter WJ, Schmechel D, St. George-Hyslop PH, Pericak-Vance MA, Joo SH et al. Association of apolipoprotein E allele 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993; 43: 1467-72.
28. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC, Jr. et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genet 1994; 7: 1804.
29. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988; 240: 622-30.
30. Poirier J, Delisle M-C, Quirion R, Aubert I, Rocheford J, Rousse I et al. Apolipoprotein E4, cholinergic integrity, synaptic plasticity and Alzheimer's disease. I: Roses AD, Weisgraber KH, Christen Y, eds. Apolipoprotein E and Alzheimer's disease. Berlin: Springer-Verlag, 1996: 20-8.
31. Weisgraber KH. Apolipoprotein E: structure-function relationships. Adv Prot Chem 1994; 45: 249-302.
32. Gerdes LU, Klausen IC, Sihm I, Færgeman O. Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genet Epidemiol 1992; 9: 155-67.
33. Johannsen P, Jakobsen JK, Jørgensen AL. Apolipoprotein E genotyper hos patienter udredt for demens. Ugeskr Læger 1997; 159: 5658-61.
34. Polvikoski T, Sulkava R, Haltia M, Kainulainen K, Vuorio A, Verkkoniemi A et al. Apolipoprotein E, dementia, and cortical deposition of β-amyloid protein. N Engl J Med 1995; 333: 1242-7.
35. Chartier-Harlin M-C, Parfitt M, Legrain S, Pérez-Tur J, Brousseau T, Evans A et al. Apolipoprotein E, ε4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet 1994; 3: 569-74.
36. Van Duijn CM, de Knijff P, Cruts M, Wehnert A, Havekes LM, Hofman A et al. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nature Genet 1994; 7: 74-8.
37. Nathan BP, Chang K-C, Bellosta S, Brisch E, Ge N, Mahley RW et al. The inhibitory effect of apolipoprotein E4 on neunte outgrowth is associated with microtubule depolymerization. J Biol Chem 1995; 270: 19791-9.
38. Lovestone S, Anderton BH, Hartley C, Jensen TG, Jorgensen AL. The intracellular fate of apolipoprotein E is tau dependent and apoe allele-specific. Neuroreport 1996; 7: 1005-8.
39. National Institute on Ageing/Alzheimer's Association Working Group. Apolipoprotein E genotyping in Alzheimer's disease. Lancet 1996; 347: 1091-5.
40. Writing Committee Lancet Conference 1996. The challenge of the dementias. Lancet 1996; 347: 1303-7.